Dorsey & Whitney Trust’s AbbVie ABBV Stock Holding History

Dorsey & Whitney Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.34M	Buy	29,158 +1,219	+4%	+$270K	0.35%	65
2025 Q4	$6.38M	Sell	27,939 -4,746	-15%	-$1.08M	0.34%	67
2025 Q3	$7.57M	Buy	32,685 +90	+0.3%	+$18.3K	0.4%	54
2025 Q2	$6.05M	Sell	32,595 -3,411	-9%	-$634K	0.32%	70
2025 Q1	$7.54M	Buy	36,006 +399	+1%	+$77.6K	0.44%	55
2024 Q4	$6.33M	Buy	35,607 +182	+0.5%	+$33.5K	0.35%	65
2024 Q3	$7M	Buy	35,425 +10,926	+45%	+$2.04M	0.37%	52
2024 Q2	$4.2M	Sell	24,499 -573	-2%	-$94.9K	0.29%	88
2024 Q1	$4.57M	Buy	25,072 +336	+1%	+$57.9K	0.31%	77
2023 Q4	$3.83M	Buy	24,736 +60	+0.2%	+$8.75K	0.29%	87
2023 Q3	$3.68M	Buy	24,676 +217	+0.9%	+$31.9K	0.32%	83
2023 Q2	$3.3M	Sell	24,459 -4	-0%	-$587	0.27%	93
2023 Q1	$3.9M	Sell	24,463 -26	-0.1%	-$3.98K	0.35%	76
2022 Q4	$3.94M	Sell	24,489 -29	-0.1%	-$4.45K	0.38%	70
2022 Q3	$3.29M	Buy	24,518 +688	+3%	+$98.7K	0.34%	70
2022 Q2	$3.65M	Buy	23,830 +293	+1%	+$44.8K	0.37%	65
2022 Q1	$3.82M	Buy	23,537 +1,917	+9%	+$278K	0.33%	74
2021 Q4	$2.92M	Buy	21,620 +2,607	+14%	+$308K	0.25%	92
2021 Q3	$2.05M	Sell	19,013 -873	-4%	-$99.8K	0.19%	115
2021 Q2	$2.24M	Sell	19,886 -1,520	-7%	-$171K	0.21%	108
2021 Q1	$2.32M	Sell	21,406 -1,436	-6%	-$154K	0.23%	101
2020 Q4	$2.45M	Buy	22,842 +839	+4%	+$80.6K	0.28%	89
2020 Q3	$1.93M	Buy	22,003 +13	+0.1%	+$1.22K	0.26%	99
2020 Q2	$2.16M	Buy	21,990 +2,248	+11%	+$198K	0.3%	81
2020 Q1	$1.5M	Sell	19,742 -207	-1%	-$17.6K	0.25%	103
2019 Q4	$1.76M	Buy	19,949 +2,469	+14%	+$205K	0.24%	106
2019 Q3	$1.32M	Buy	17,480 +3,493	+25%	+$239K	0.19%	117
2019 Q2	$1.02M	Buy	13,987 +248	+2%	+$19.5K	0.16%	127
2019 Q1	$1.11M	Sell	13,739 -3,793	-22%	-$310K	0.17%	121
2018 Q4	$1.62M	Sell	17,532 -881	-5%	-$77.5K	0.29%	86
2018 Q3	$1.74M	Sell	18,413 -986	-5%	-$93.5K	0.27%	89
2018 Q2	$1.8M	Buy	19,399 +904	+5%	+$88.3K	0.31%	85
2018 Q1	$1.75M	Sell	18,495 -755	-4%	-$82.9K	0.32%	74
2017 Q4	$1.86M	Sell	19,250 -664	-3%	-$62.6K	0.34%	72
2017 Q3	$1.77M	Sell	19,914 -872	-4%	-$66.4K	0.35%	71
2017 Q2	$1.51M	Buy	20,786 +761	+4%	+$51.2K	0.3%	76
2017 Q1	$1.3M	Buy	20,025 +485	+2%	+$30.5K	0.27%	80
2016 Q4	$1.22M	Sell	19,540 -235	-1%	-$14.3K	0.28%	81
2016 Q3	$1.25M	Sell	19,775 -2,642	-12%	-$171K	0.29%	82
2016 Q2	$1.39M	Buy	22,417 +480	+2%	+$29.2K	0.32%	73
2016 Q1	$1.25M	Buy	21,937 +880	+4%	+$49K	0.31%	75
2015 Q4	$1.25M	Buy	21,057 +645	+3%	+$37.1K	0.33%	73
2015 Q3	$1.11M	Sell	20,412 -903	-4%	-$58.8K	0.31%	76
2015 Q2	$1.43M	Buy	21,315 +124	+0.6%	+$8.1K	0.37%	69
2015 Q1	$1.24M	Sell	21,191 -10	-0%	-$604	0.31%	76
2014 Q4	$1.39M	Sell	21,201 -1,931	-8%	-$122K	0.36%	68
2014 Q3	$1.34M	Sell	23,132 -189	-0.8%	-$10.5K	0.36%	66
2014 Q2	$1.32M	Sell	23,321 -175	-0.7%	-$9.18K	0.29%	67
2014 Q1	$1.21M	Sell	23,496 -2,909	-11%	-$147K	0.28%	68
2013 Q4	$1.39M	Buy	26,405 +3,942	+18%	+$194K	0.38%	64
2013 Q3	$1.01M	Buy	22,463 +2,439	+12%	+$108K	0.3%	70
2013 Q2	$828K	Buy	+20,024	New	+$876K	0.27%	72

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dorsey & Whitney Trust's ABBV Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its AbbVie (ABBV) stake by 4.4% in Q1 2026, buying an estimated $270K and bringing the position to 29,158 shares worth $6.34M. The position accounts for 0.35% of the portfolio, ranked #65.

Dorsey & Whitney Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.57M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Dorsey & Whitney Trust held 29,158 shares of AbbVie worth $6.34M as of Q1 2026.
Dorsey & Whitney Trust bought 1,219 AbbVie shares in Q1 2026, an estimated $270K.
AbbVie made up 0.35% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #65 holding.
Dorsey & Whitney Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Dorsey & Whitney Trust's AbbVie position peaked at $7.57M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.